The State of Texas Top Legal Officer Takes Legal Action Against Acetaminophen Manufacturers Concerning Autism Spectrum Allegations

The top legal official in Texas Ken Paxton is suing the makers of Tylenol, asserting the companies hid safety concerns that the drug presented to children's neurological development.

This legal action arrives a month after President Donald Trump advocated an unproven link between using Tylenol - also known as paracetamol - during pregnancy and autism spectrum disorder in children.

Paxton is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever suggested for pregnant women, and the current manufacturer, which currently produces it.

In a statement, he claimed they "misled consumers by making money from suffering and promoting medication ignoring the dangers."

Kenvue asserts there is lacking scientific proof tying Tylenol to autism spectrum disorder.

"These corporations misled for generations, knowingly endangering countless individuals to line their pockets," Paxton, from the Republican party, said.

The manufacturer stated officially that it was "seriously troubled by the perpetuation of misinformation on the safety of acetaminophen and the possible consequences that could have on the welfare of US mothers and children."

On its website, the company also stated it had "regularly reviewed the relevant science and there is lacking reliable evidence that indicates a verified association between using paracetamol and autism."

Associations representing physicians and healthcare providers agree.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the primary component in Tylenol - is a restricted selection for women during pregnancy to treat pain and fever, which can present serious health risks if not addressed.

"In multiple decades of investigation on the consumption of acetaminophen in pregnancy, not a single reputable study has definitively established that the consumption of acetaminophen in any stage of pregnancy leads to neurodevelopmental disorders in young ones," the organization stated.

The court filing cites recent announcements from the previous government in claiming the drug is allegedly unsafe.

Recently, the former president raised alarms from health experts when he told expectant mothers to "fight like hell" not to use acetaminophen when sick.

The FDA then released a statement that medical professionals should think about restricting the consumption of Tylenol, while also declaring that "a direct connection" between the drug and autism in minors has remains unverified.

The Health Department head Kennedy, who oversees the FDA, had pledged in April to initiate "extensive scientific investigation" that would establish the source of autism in a short period.

But authorities advised that identifying a unique factor of autism spectrum disorder - considered by experts to be the consequence of a intricate combination of genetic and surrounding conditions - would be difficult.

Autism spectrum disorder is a form of enduring cognitive variation and impairment that influences how individuals experience and relate to the world, and is identified using physician assessments.

In his court filing, Paxton - who supports Trump who is running for the Senate - claims Kenvue and J&J "willfully ignored and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

The lawsuit seeks to make the companies "eliminate any commercial messaging" that asserts Tylenol is safe for expectant mothers.

The court case echoes the concerns of a collection of guardians of young ones with autism and attention deficit hyperactivity disorder who sued the producers of acetaminophen in two years ago.

A federal judge threw out the lawsuit, stating studies from the family's specialists was not conclusive.